Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) fell 1.2% on Thursday . The stock traded as low as $24.38 and last traded at $24.38. 200 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The business’s 50-day moving average price is $24.38 and its 200-day moving average price is $24.38. The firm has a market capitalization of $6.64 billion, a PE ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:SWTUY) is a Stockholm-based biopharmaceutical company specializing in the development, manufacturing and commercialization of therapies for rare diseases and specialty care. The company’s portfolio spans treatments in hematology, immunology and metabolic disorders. Its research and development efforts focus on addressing unmet medical needs by advancing both proprietary and in-licensed drug candidates through clinical and regulatory pathways.
The company’s flagship offerings include clotting factor products for hemophilia, enzyme replacement therapies for lysosomal storage disorders and targeted immunomodulators for inflammatory conditions.
Further Reading
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
